Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAZT6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,849
Award facts
- Contract value 100% obligated
- $28,849.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,849.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) with an ultimate completion date of June 20, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications to support military healthcare systems and other government agencies.
XELJANZ XR is a targeted immunosuppressant medication used primarily for rheumatoid arthritis treatment. This delivery order demonstrates AmerisourceBergen's ongoing role as a pharmaceutical prime vendor for the Defense Health Agency and other federal healthcare systems. The company's comprehensive IDC with DLA Troop Support Medical enables it to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, supporting military personnel and veteran healthcare needs globally. AmerisourceBergen competes for individual delivery orders under this vehicle alongside other qualified pharmaceutical distributors as part of DLA's strategic approach to pharmaceutical prime vendor programs.
Quick answers
Who was awarded contract SPE2DB25FAZT6?
SPE2DB25FAZT6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FAZT6 worth?
The government has obligated $28,849 on SPE2DB25FAZT6.
Is contract SPE2DB25FAZT6 an order under another contract?
Yes. SPE2DB25FAZT6 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAZT6 competed?
The extent of competition for SPE2DB25FAZT6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award